Document is current
Any future updates will be listed below
-
Authors
Wang, Xin
Cao, Chen http://orcid.org/0000-0002-3739-5240
Tan, Xiangyu
Liao, Xueyao
Du, Xiaofang
Wang, Xueqian
Liu, Ting
Gong, Danni
Hu, Zheng
Tian, Xun
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82172584, 32171465, 82102392, 81902663)
General Program of Natural Science Foundation of Guangdong Province of China (2021A1515012438)
Guangdong Basic and Applied Basic Research Foundation (2020A1515110170)
application foundation frontier project of Wuhan Science and Technology Bureau (2020020601012324)
Medical Research Project of Wuhan Municipal Health Commission (WX20Q05, WX21Q09)
- License Information
-
More Information
Article History
Received: 31 October 2022
Accepted: 17 May 2023
First Online: 12 June 2023
Declarations
:
: The clinical study protocol was approved by the Human Research Ethics Committee of the Tongji Hospital of Huazhong University of Science and Technology (TJ-IRB20180505). The procedures are in accordance with the Helsinki Declaration of 1975. Written informed consent was obtained from all participants. Animal experiments were approved by the institutional committee at Wuhan Myhalic Biotechnological Co., Ltd.
: Not applicable.
: The authors declare that they have no competing interests.
